Blueprint Medicines Analysts Recommendations and Consensus

BPMC -- USA Stock  

USD 63.76  1.47  2.36%

The current analyst and expert consensus on Blueprint Medicines is Buy with 0 strong sell and 4 strong buy opinions. The current projected target price consensus is 40.5 with 4 analysts opinions. The most common way Blueprint Medicines analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Blueprint Medicines executives and customers to further validate their buy or sell advice. Note, the total number of analysists currently providing their opinion is not significant to determine adequate consensus on Blueprint Medicines. We strongly encourage you to use your own analysis of Blueprint Medicines to validate this buy or sell advice. Blueprint Medicines buy or sell recommendation module provides average expert sentiment on the projected Blueprint Medicines target price to derive its highest and lowest estimates based on projected price volatility of 4.795. Check also Macroaxis Advice on Blueprint Medicines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Blueprint Medicines Target Price Consensus

Number of Opinions6
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Blueprint Medicines Target Price Projection

Current Price

Blueprint Medicines Market Quote
Low Price63.72Odds
High Price66.61Odds

63.76

Target Price

Analyst Consensus On Target Price
Low Estimate34.0Odds
High Estimate45.0Odds
Number of Analysts4
Standard Deviation4.795

40.5

Blueprint Medicines Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Artificial Intelligence
Purchased over 20 shares
Traded few hours ago for 106.27
Driverless Cars
Purchased over 200 shares
Traded few hours ago for 10.56
Driverless Cars
Purchased over 70 shares
Traded few hours ago for 39.4
Social Domain
Purchased few shares
Traded few hours ago for 1184.91
Baby Boomer Prospects
Purchased over 40 shares
Traded few hours ago for 69.22
Artificial Intelligence
Purchased few shares
Traded few hours ago for 209.94
Check also Macroaxis Advice on Blueprint Medicines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">